SL
SELLAS Life Sciences Group, Inc.
SLS · NASDAQ
$11.38 -2.39% (-$0.28)
1M -20.66%
Market Cap $2.12B
P/E Ratio -
Div. Yield -
ROE 35.91%
Bulios Fair Price
$7.92
30.4% downside
Trenutna cena
$11.38
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SLS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 15.38x
EV/EBITDA N/A
P/S N/A
Growth
100 /100
Growing Book val. growth 144.46%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 35.91%
ROA 22.33%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 18.83x
Debt/Equity 0.01x
Net debt/EBITDA N/A
Stability
44 /100
Moderate EPS volatility 12.80%
Profitable years 0
Beta 2.53x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SLS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Angelos Stergiou
Employees
13
Headquarters
New York
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report